Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of the role of ischemia modified albumin in neonatal hypoxic-ischemic encephalopathy

  • Talat, Mohamed A. (Department of Pediatrics, Faculty of Medicine, Zagazig University) ;
  • Saleh, Rabab M. (Department of Pediatrics, Faculty of Medicine, Zagazig University) ;
  • Shehab, Mohammed M. (Department of Pediatrics, Faculty of Medicine, Zagazig University) ;
  • Khalifa, Naglaa A. (Department of Clinical Pathology, Faculty of Medicine, Zagazig University) ;
  • Sakr, Maha Mahmoud Hamed (Department of Clinical Pathology, Faculty of Medicine, Zagazig University) ;
  • Elmesalamy, Walaa M. (Ministry of Health)
  • Received : 2019.11.11
  • Accepted : 2020.03.19
  • Published : 2020.08.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Birth asphyxia is a leading cause of neonatal mortality. Ischemia-modified albumin (IMA) levels may have a predictive role in the identification and prevention of hypoxic disorders, as they increase in cases of ischemia of the liver, heart, brain, bowel, and kidney. Purpose: This study aimed to assess the value of IMA levels as a diagnostic marker for neonatal hypoxic-ischemic encephalopathy (HIE). Methods: Sixty newborns who fulfilled 3 or more of the clinical and biochemical criteria and developed HIE as defined by Levene staging were included in our study as the asphyxia group. Neonates with congenital malformation, systemic infection, intrauterine growth retardation, low-birth weight, cardiac or hemolytic disease, family history of neurological diseases, congenital or perinatal infections, preeclampsia, diabetes, and renal diseases were excluded from the study. Sixty healthy neonates matched for gestational age and with no maternal history of illness, established respiration at birth, and an Apgar score ≥7 at 1 and 5 minutes were included as the control group. IMA was determined by double-antibody enzyme-linked immunosorbent assay of a cord blood sample collected within 30 minutes after birth. Results: Cord blood IMA levels were higher in asphyxiated newborns than in controls (250.83±36.07 pmol/mL vs. 120.24±38.9 pmol/mL). Comparison of IMA levels by HIE stage revealed a highly significant difference among them (207.3±26.65, 259.28±11.68, 294.99±4.41 pmol/mL for mild, moderate, and severe, respectively). At a cutoff of 197.6 pmol/mL, the sensitivity was 84.5%, specificity was 86%, positive predictive value was 82.8%, negative predictive value was 88.3%, and area under the curve was 0.963 (P<0.001). Conclusion: IMA levels can be a reliable marker for the early diagnosis of neonatal HIE and can be a predictor of injury severity.

Keywords

References

  1. Distefano G, Pratico AD. Actualities on molecular pathogenesis and repairing processes of cerebral damage in perinatal hypoxic-ischemic encephalopathy. Ital J Pediatr 2010;36:63. https://doi.org/10.1186/1824-7288-36-63.
  2. Vannucci SJ, Hagberg H. Hypoxia-ischemia in the immature brain. J Exp Biol 2004;207(Pt 18):3149-54. https://doi.org/10.1242/jeb.01064
  3. Florio P, Abella R, Marinoni E, Di Iorio R, Li Volti G, Galvano F, et al. Biochemical markers of perinatal brain damage. Front Biosci (Schol Ed) 2010;2:47-72.
  4. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000;19:311-5. https://doi.org/10.1016/S0736-4679(00)00255-9
  5. Shen XL, Lin CJ, Han LL, Lin L, Pan L, Pu XD. Assessment of ischemiamodified albumin levels for emergency room diagnosis of acute coronary syndrome. Int J Cardiol 2011;149:296-8. https://doi.org/10.1016/j.ijcard.2010.01.013
  6. Sbarouni E, Georgiadou P, Kremastinos DT, Voudris V. Ischemia modified albumin: is this marker of ischemia ready for prime time use? Hellenic J Cardiol 2008;15:260-6.
  7. Hekimoglu B, Yakup Aslan Y, Mutlu M, Mentese A, Karahan SC. Predictive values of Ischemia modified albumin in neonatal sepsis. Turk J Biochem 2017;3:245-50.
  8. Kahveci H, Tayman C, Laoglu F, Celik HT, Kavas N, Kilic O et al. Serum ischemia-modified albumin in preterm babies with respiratory distress syndrome. Indian J Clin Biochem 2016;31:38-42. https://doi.org/10.1007/s12291-015-0494-0
  9. Ozdemir OM, Ozdemir E, Enli Y, Oztekin O, Ergin H. Ischemia-modified albumin in preterm infants born to mothers with pre-eclampsia. Pediatr Int 2018;60:553-9. https://doi.org/10.1111/ped.13563
  10. Florio P, Frigiola A, Battista R, Abdalla Ael H, Gazzolo D, Galleri L, et al. Activin A in asphyxiated full term newborns with hypoxic ischemic encephalopathy. Front Biosci (Elite Ed) 2010;2:36-42.
  11. Levene MI, Kornberg J, Williams THC. The incidence and severity of post-asphyxial encephalopathy in full-term infants. Early Hum Dev 1985;11:21-8. https://doi.org/10.1016/0378-3782(85)90115-X
  12. Finer NN, Robertson CM, Richards RT, Pinnell LE, Peters KL. Hypoxicischemic encephalopathy in term neonates: perinatal factors and outcome. J Pediatr 1981;98:112-7. https://doi.org/10.1016/s0022-3476(81)80555-0
  13. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score expanded to include extremely premature infants. J Pediatr 1991;119:417-23. https://doi.org/10.1016/s0022-3476(05)82056-6
  14. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol 1976;33:696-705. https://doi.org/10.1001/archneur.1976.00500100030012
  15. Fatrakul S, Praisuwanna P, Thaitumyanon P. Risk factors for hypoxic. Ischemic encephalopathy in asphyxiated newborn infants. J Med Assoc Thai 2006;89:322-8.
  16. Lee AC, Kozuki N, Blencowe H, Vos T, Adil Bahalim A, Gary L. et al. Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990. Pediatr Res 2013;74 Suppl 1:50-72. https://doi.org/10.1038/pr.2013.206
  17. Biswas S, Sarkar P, Chakraborty I, Ghosh S, Halder RC. Study of cord blood ischemia-modified albumin levels in the evaluation of birth asphyxia. J Invest Biochem 2014;3:46-50. https://doi.org/10.5455/jib.20130930110304
  18. Trevisanuto D, Picco G, Golin R, Doglioni N, Altinier S, Zaninotto M, et al. Cardiac troponin I in asphyxiated neonates. Biol Neonate 2006;89:190-3. https://doi.org/10.1159/000089795
  19. Kirimi E, Peker E, Tuncer O, Yapicioglu H, Narli N, Satar M. Increased serum malondialdehyde level in neonates with hypoxic-ischaemicencephalopathy: prediction of disease severity. J Int Med Res 2010;38:220-6. https://doi.org/10.1177/147323001003800126
  20. Hill CA, Fitch RH. Sex differences in mechanisms and outcome of neonatal hypoxia-ischemia in rodent models: implications for sex-specific neuroprotection in clinical neonatal practice. Neurol Res Int 2012;2012:867531. https://doi.org/10.1155/2012/867531
  21. Greenough A, Lagercrantz H, Pool J, Dahlin F. Plasma catecholamine levels in preterm infants. Effect of birth asphyxia and Apgar score. Acta Paediatr Scand 1987;76:54-9. https://doi.org/10.1111/j.1651-2227.1987.tb10414.x
  22. Lang JT, McCullough LD. Pathways to ischemic neuronal cell death: are sex differences relevant? J Trans Med 2008;6:33. https://doi.org/10.1186/1479-5876-6-33
  23. Campbell O, Gipson R, el-Mohandes A, Issa AH, Matta N, Mansour E, et al. The Egypt National Perinatal/Neonatal Mortality Study 2000. J Perinatol 2004;24:284-9. https://doi.org/10.1038/sj.jp.7211084
  24. Carli G, Reiger I, Evans N. One-year neurodevelopmental outcome after moderate newborn hypoxic ischaemic encephalopathy J Paediatr Child Health 2004;40:217-20. https://doi.org/10.1111/j.1440-1754.2004.00341.x
  25. Toh VC. Early predictors of adverse outcome in term infants with postasphyxial hypoxic ischaemic encephalpathy. Acta Paediatr 2000;89:343-7. https://doi.org/10.1080/080352500750028500
  26. Caliskan E, Doger E, Cakiroglu Y, Duman C, Turker G, Yucesoy I. Cord blood cardiac troponin I and creatine kinase MB levels in poor neonatal outcomes. J Turkish German Gynecol Assoc 2006;7:98-102.
  27. Brucknerova I, Ujhazy E, Dubovicky M, Mach M. Early assessment of the severity of asphyxia in term newborns using parameters of blood count. Interdiscip Toxicol 2008;1(3-4):211-3. https://doi.org/10.2478/v10102-010-0043-x
  28. Shang Y, Mu L, Guo X, Li Y, Wang L, Yang W, et al. Clinical significance of interleukin-6, tumor necrosis $factor-{\alpha}$ and high-sensitivity C-reactive protein in neonates with hypoxic-ischemic encephalopathy. Exp Ther Med 2014;8:1259-62. https://doi.org/10.3892/etm.2014.1869
  29. Schmidt JW, Walsh WF. Hypoxic-ischemic encephalopathy in preterm infants. J Neonatal Perinatal Med 2010;3:277-84. https://doi.org/10.3233/NPM-2010-0126
  30. Khan KS, Bachmann LM, Ter Riet G. Systematic reviews with individual patient data meta-analysis to evaluate diagnostic tests. Eur J Obstet Gynecol Reprod Biol 2003;108:121-5. https://doi.org/10.1016/S0301-2115(03)00098-8
  31. Gazzolo D, Abella R, Marinoni E, Iorio R, Li Volti G, Galvano F, et al. Circulating biochemical markers of brain damage in infants complicated by ischemia reperfusion injury. Cardiovasc Hematol Agents Med Chem 2009;7:108-26. https://doi.org/10.2174/187152509787847119
  32. Gugliucci A, Hermo R, Monroy C, Numaguchi M, Kimura S. Ischemiamodified albumin levels in cord blood: a case-control study in uncomplicated and complicated deliveries. Clin Chim Acta 2005;362:155-60. https://doi.org/10.1016/j.cccn.2005.06.014
  33. Kar K, Biswas M, Das S, BiswasT, Biswas J, Sarkar C. Cord blood ischemia modified albumin may predict the oxidative stress in newborns, a prospective study in Kolkata. Intern J of Health Sci Res 2015;5:178-83.
  34. Iacovidou N, Briana DD, Boutsikou M, Liosi S, Baka S, Boutsikou T, et al. Cord blood ischemia-modified albumin levels in normal and intrauterine growth restricted pregnancies. Mediators Inflamm 2008;2008:523081. https://doi.org/10.1155/2008/523081
  35. Kumral A, Okyay E, Guclu S, Gencpinar P, Islekel GH, Oguz SS, et al. Cord blood ischemia-modified albumin: is it associated with abnormal Doppler findings in complicated pregnancies and predictive of perinatal asphyxia? J Obstet Gynaecol Res 2013;39:663-71. https://doi.org/10.1111/j.1447-0756.2012.02055.x
  36. Dursun A, Okumus N, Zenciroglu A. Ischemia-modified albumin (IMA): could it be useful to predict perinatal asphyxia? J Matern Fetal Neonatal Med 2012;25:2401-5. https://doi.org/10.3109/14767058.2012.697943

Cited by

  1. Ischemia-Modified Albumin: Origins and Clinical Implications vol.2021, 2020, https://doi.org/10.1155/2021/9945424